/spl beta/"-Al/sub 2/O/sub 3/ tubes
Synthesis, Characterization and Gas Sensing Performance of PbMnO<sub>3</sub>, PbMnO<sub>3 </sub>: SiO<sub>2</sub> and PbMnO<sub>3 </sub>: Al<sub>2</sub>O<sub>3</sub>
10
Comparative Study on Convection and Wall Characteristics of Al<sub>2</sub>O<sub>3</sub> water Nanofluid Flow inside a Miniature Tube
13
<p>Eco-Friendly and Systematic Study for Synthesis of La<sup>3+</sup>/α-Al<sub>2</sub>O<sub>3</sub> Nanoparticles: Antibacterial Activity Against Pathogenic Microbial Strains</p>
10
Optimization of Process Parameters of Methane Decomposition in a Fluidized Bed Reactor UsingNi-Cu/Al<sub>2</sub>O<sub>3</sub> Catalysts - Volume 3 Number 1 (Feb. 2012) - IJCEA
5
Effect of Alkaline and Alkaline Earth Metal Oxides Addition on the Glass Formation and Crystallization of ZnO Al<sub>2</sub>O<sub>3</sub> SiO<sub>2</sub> Glasses
13
<p>Local ozone (O<sub>2</sub>–O<sub>3</sub>) versus corticosteroid injection efficacy in plantar fasciitis treatment: a double-blinded RCT</p>
9
<p>Nd<sub>2</sub>O<sub>3</sub> Nanoparticles Induce Toxicity and Cardiac/Cerebrovascular Abnormality in Zebrafish Embryos via the Apoptosis Pathway</p>
14
<p>La<sub>2</sub>O<sub>3</sub> Nanoparticles Induce Reproductive Toxicity Mediated by the Nrf-2/ARE Signaling Pathway in Kunming Mice</p>
17
<p>Oxygen-Ozone (O<sub>2</sub>-O<sub>3</sub>) Therapy in Peripheral Arterial Disease (PAD): A Review Study</p>
16
Biosafety evaluation of Janus Fe<sub>3</sub>O<sub>4</sub>-TiO<sub>2</sub> nanoparticles in Sprague Dawley rats after intravenous injection
15
Polyetherimide-grafted Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> nanoparticles as theranostic agents for simultaneous VEGF siRNA delivery and magnetic resonance cell imaging
13
<p>GPX2 suppression of H<sub>2</sub>O<sub>2</sub> stress regulates cervical cancer metastasis and apoptosis via activation of the β-catenin-WNT pathway</p>
13
Effect of plant extracts on H<sub>2</sub>O<sub>2</sub>-induced inflammatory gene expression in macrophages
10
Biocompatibility of Fe<sub>3</sub>O<sub>4</sub>/DNR magnetic nanoparticles in the treatment of hematologic malignancies
6
Pharmacokinetic parameters and tissue distribution of magnetic Fe<sub>3</sub>O<sub>4</sub> nanoparticles in mice
6
Biocompatibility of Fe<sub>3</sub>O<sub>4</sub>@Au composite magnetic nanoparticles in vitro and in vivo
15
In vitro and in vivo targeting imaging of pancreatic cancer using a Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> nanoprobe modified with anti-mesothelin antibody
13
Fe<sub>3</sub>O<sub>4</sub>-based PLGA nanoparticles as MR contrast agents for the detection of thrombosis
14
Biocompatibility of magnetic Fe<sub>3</sub>O<sub>4</sub> nanoparticles and their cytotoxic effect on MCF-7 cells
10
Preparation of Fe<sub>3</sub>O<sub>4</sub> magnetic nanoparticles coated with gallic acid for drug delivery
12